1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Peer Reviewed Cancer Research Program (PRCRP) is sponsored by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). The PRCRP supports high-impact research across various cancer types, including colorectal cancer.
It funds hypothesis-driven, innovative, and mature research projects, and clinical trials that address critical scientific or clinical cancer issues and have the potential for major near-term impact. The program emphasizes innovation and relevance to military health.
Get alerted about grants like this
Save a search for “U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Researchers and institutions whose projects address at least one of the strategic goals for a topic area (including colorectal cancer) and at least one of the military health focus areas. Specific eligibility criteria vary by award mechanism. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1.5M or $2M (Partnering PI Option) over 3 years for Impact Award; up to $600,000 over 2 years for Investigator-Initiated Research Award; up to $4.5M over 4 years for Clinical Trial Award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Peer Reviewed Cancer Research Program (PRCRP) are due June 26, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Peer Reviewed Cancer Research Program (PRCRP) is funded by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Peer Reviewed Cancer Research Program (Idea Award – HT942526PRCRPIA) is sponsored by US Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). Supports innovative basic research that may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Emphasizes innovation and preliminary data is not required.
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Discovery Award supports novel, untested, high-risk, high-reward research projects with the potential to provide new insights, paradigms, technologies, or applications and with a potential to generate preliminary data that will lay the foundation for future projects. The application must address a critical problem or question in the field of research and/or patient care in a congressionally directed FY26 PRMRP topic area and one of the FY26 PRMRP portfolio-specific strategic goals.Distinctive Features: Applications must not include preliminary data. The focus of this award mechanism is innovation. Research proposed to this mechanism should be pioneering and revolutionary, and the outcomes generated by the award are expected to generate robust preliminary data that will lay the groundwork for future avenues of scientific investigation or product development.Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $11.165M to fund approximately 29 Discovery Award applications with total cost caps of $385,000 per award. The maximum period of performance is 2 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. Funding Opportunity Number: HT942526PRMRPDA. Assistance Listing: 12.420. Funding Instrument: CA,G. Category: ST. Award Amount: $11.2M total program funding.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article